Tennessee Regulators Find Over 650 Unlicensed Hemp Cannabinoid Sellers
Tennessee regulators have found more than 650 unlicensed hemp cannabinoid product sellers operating in the state. This unregulated market poses significant safety risks due to unknown potency and contaminants. Clinicians should be aware of these…
Court Grants Dismissal of THC Potency Action – Law360 Analysis
The court's dismissal of cannabis THC potency limits challenges leaves regulatory authority with state agencies. Clinicians must counsel patients on high potency cannabis risks. Understanding cannabis THC potency limits is essential for safe clinical…
How Growing Cannabis Use is Changing Clinical Treatment Approaches
Changing cannabis use patterns are reshaping clinical treatment approaches. Clinicians must update diagnostic protocols to address evolving potency and consumption methods. Understanding these changes is essential for effective cannabis use disorder…
US Farmers Face Challenges Amid Hemp THC Ban Uncertainty
Hemp THC regulations impact farmers by creating uncertainty in cultivation and processing decisions. This disruption affects the supply chain for hemp-derived cannabinoids. Patients and clinicians must navigate potential product inconsistencies and…
Evil Kermit
When your patient asks if cannabis will cure their condition versus when you explain the actual evidence for symptom management. The difference between hope and realistic therapeutic goals. Further Reading Research DigestAM Policy Update: March 16, 2026…
Cannabinoids & Athlete Mental Health: Clinical Evidence
Retired professional athletes face unique mental health challenges, including depression and anxiety. Cannabinoid clinical trials athlete mental health research explores potential therapeutic roles. Understanding this evidence helps guide clinical…
‘An Attempt To Ban the Industry’: Dallas THC Shops React to Smokable Hemp Rule
Smokable hemp regulatory challenges in Dallas highlight tensions between evolving cannabis laws and patient safety. THCa hemp products convert to intoxicating delta-9 THC, complicating clinical understanding. Clinicians must navigate these challenges to…
CBD for Fibromyalgia: Clinical Trial Evidence Reviewed
This article reviews CBD fibromyalgia clinical trial evidence assessing its efficacy in pain reduction. The trial found CBD did not outperform placebo in fibromyalgia pain relief. Patients and clinicians should consider this evidence carefully when…
Hello everyone, greetings from Morocco
When your patient’s terpene profile discussion gets a little too geographically specific for the clinic notes. Via r/trees Further Reading Research DigestAM Policy Update: March 11, 2026 Evidence WatchCannabinoid Clinical Trials in Athlete Mental…
Connect to the Capitol: Budget Battle, Clyburn to Run Again, Tussle Over THC – WCIV
South Carolina cannabis regulation is evolving rapidly with new 2026 legislative efforts targeting hemp-derived THC products. Clinicians must understand these changes to provide accurate counseling on product safety and legality. This update highlights…
